Skip to main content
logo
BioHarvest Sciences Inc. (BHST)
NASDAQ: BHST · Real-Time Price · USD
0.00
+0.1330 (3.01%)
Apr 21, 2026, 9:44 AM EDT - Market open

BioHarvest Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
34.5125.1912.675.52.1
Revenue Growth (YoY)
37.00%98.77%130.48%161.56%430.81%
Cost of Revenue
14.0311.257.044.281.43
Gross Profit
20.4813.945.631.220.67
Selling, General & Admin
20.7416.1312.239.525.03
Research & Development
5.314.83.372.314.13
Operating Expenses
26.0520.9315.611.839.16
Operating Income
-5.58-6.99-9.97-10.61-8.49
Interest Expense
-2.72-1.24-0.94-0.51-0.81
Interest & Investment Income
0.05----
Currency Exchange Gain (Loss)
-1.83-0.080.030.230.29
Other Non Operating Income (Expenses)
-0.99-4.61-1.69-0.35-0.82
EBT Excluding Unusual Items
-11.06-12.91-12.56-11.24-9.83
Pretax Income
-11.06-12.91-12.56-11.24-9.83
Income Tax Expense
0.080.01---
Earnings From Continuing Operations
-11.14-12.91-12.56-11.24-9.83
Net Income
-11.14-12.91-12.56-11.24-9.83
Net Income to Common
-11.14-12.91-12.56-11.24-9.83
Shares Outstanding (Basic)
1816141312
Shares Outstanding (Diluted)
1816141312
Shares Change (YoY)
13.69%19.66%3.67%4.87%28.15%
EPS (Basic)
-0.60-0.80-0.93-0.86-0.79
EPS (Diluted)
-0.60-0.80-0.93-0.86-0.79
Free Cash Flow
-9.58-9.52-10-10.5-8.43
Free Cash Flow Per Share
-0.52-0.59-0.74-0.80-0.68
Gross Margin
59.34%55.35%44.45%22.17%31.87%
Operating Margin
-16.16%-27.75%-78.65%-193.02%-403.95%
Profit Margin
-32.27%-51.27%-99.15%-204.37%-467.51%
Free Cash Flow Margin
-27.77%-37.79%-78.88%-190.92%-401.24%
EBITDA
-5.11-6.54-9.58-10.33-8.43
EBITDA Margin
-14.81%-25.96%-75.57%-187.83%-
D&A For EBITDA
0.460.450.390.290.07
EBIT
-5.58-6.99-9.97-10.61-8.49
EBIT Margin
-16.16%-27.75%-78.65%-193.02%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q